GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (WBO:ALM) » Definitions » Cyclically Adjusted PS Ratio

Almirall (WBO:ALM) Cyclically Adjusted PS Ratio : 1.60 (As of Jun. 08, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Almirall Cyclically Adjusted PS Ratio?

As of today (2024-06-08), Almirall's current share price is €9.33. Almirall's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €5.83. Almirall's Cyclically Adjusted PS Ratio for today is 1.60.

The historical rank and industry rank for Almirall's Cyclically Adjusted PS Ratio or its related term are showing as below:

WBO:ALM' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.33   Med: 2.21   Max: 3.82
Current: 1.59

During the past years, Almirall's highest Cyclically Adjusted PS Ratio was 3.82. The lowest was 1.33. And the median was 2.21.

WBO:ALM's Cyclically Adjusted PS Ratio is ranked better than
59.89% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs WBO:ALM: 1.59

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Almirall's adjusted revenue per share data for the three months ended in Mar. 2024 was €1.189. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €5.83 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Almirall Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Almirall's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall Cyclically Adjusted PS Ratio Chart

Almirall Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.83 2.18 2.14 - -

Almirall Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.52 1.33 - 1.41

Competitive Comparison of Almirall's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Almirall's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Almirall's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Almirall's Cyclically Adjusted PS Ratio falls into.



Almirall Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Almirall's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=9.33/5.83
=1.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almirall's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Almirall's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.189/122.7621*122.7621
=1.189

Current CPI (Mar. 2024) = 122.7621.

Almirall Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 1.272 101.306 1.541
201403 1.141 100.139 1.399
201406 1.261 101.081 1.531
201409 1.201 100.441 1.468
201412 1.173 100.251 1.436
201503 1.049 99.474 1.295
201506 1.043 101.138 1.266
201509 0.895 99.559 1.104
201512 0.974 100.268 1.193
201603 1.108 98.638 1.379
201606 1.136 100.333 1.390
201609 1.086 99.737 1.337
201612 1.079 101.842 1.301
201703 1.096 100.896 1.334
201706 0.804 101.848 0.969
201709 0.889 101.524 1.075
201712 0.908 102.975 1.082
201803 1.103 102.122 1.326
201806 1.012 104.165 1.193
201809 1.001 103.818 1.184
201812 1.240 104.193 1.461
201903 1.276 103.488 1.514
201906 1.192 104.612 1.399
201909 1.176 103.905 1.389
201912 6.151 105.015 7.191
202003 1.383 103.469 1.641
202006 1.099 104.254 1.294
202009 1.036 103.521 1.229
202012 1.088 104.456 1.279
202103 1.239 104.857 1.451
202106 1.153 107.102 1.322
202109 1.054 107.669 1.202
202112 1.168 111.298 1.288
202203 1.274 115.153 1.358
202206 1.204 118.044 1.252
202212 0.000 117.650 0.000
202303 1.281 118.948 1.322
202306 1.122 120.278 1.145
202312 0.000 121.300 0.000
202403 1.189 122.762 1.189

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Almirall  (WBO:ALM) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Almirall Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Almirall's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Almirall (WBO:ALM) Business Description

Industry
Traded in Other Exchanges
Address
Ronda General Mitre 151, Barcelona, ESP, 08022
Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.

Almirall (WBO:ALM) Headlines

From GuruFocus

ALFI Inc: A Little Known Yet Compelling Ad-Tech Play

By Ishan Majumdar Ishan Majumdar 05-07-2021

Alfi: Solid Growth Potential Lies Ahead

By Ishan Majumdar Ishan Majumdar 06-02-2021